SCHEMBL12421897

SCHEMBL12421897

CNCCC(=O)NC(C)NC(=O)C(C)N1C(=O)C=CC1=O

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13448309 0.90 POLB (0.35) POLB
SCHEMBL12507623 0.86 ACACB (0.36) POLB
SCHEMBL12505905 0.86 HTT (0.35) POLB
SCHEMBL12508926 0.85 MEN1 (0.35) —
SCHEMBL2610533 0.82 AKT1 (0.33) —
SCHEMBL11955673 0.81 POLB (0.32) POLB
SCHEMBL11955679 0.79 POLB (0.32) POLB
SCHEMBL13185397 0.79 POLB (0.37) POLB
SCHEMBL2610530 0.77 POLB (0.36) POLB
SCHEMBL12521585 0.76 HDAC3 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110171163-A1 POLYMER CONJUGATES OF ZICONOTIDE PEPTIDES NEKTAR THERAPEUTICS (US) 2011-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171163-A1 POLYMER CONJUGATES OF ZICONOTIDE PEPTIDES NGLY1, VIP, IAPP POLB 2492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback